Complete Guide to
What is Ayahuasca?
The sacred Amazonian brew, its chemistry, traditions, ceremony, and what the research actually shows — explained clearly.
Ayahuasca is a sacred plant medicine brew from the Amazon, combining the Banisteriopsis caapi vine with DMT-containing plants such as Psychotria viridis, used for centuries by indigenous peoples across South America for healing, ceremony, and spiritual knowledge.
At a Glance
| What it is | A brew, not a single plant |
| Active compound | DMT (dimethyltryptamine), made orally active by MAOI alkaloids in the vine |
| Duration | 4 to 6 hours (sometimes longer) |
| Primary traditions | Colombian, Peruvian, Brazilian, Ecuadorian Amazonian |
| US legal status | Schedule I controlled substance; narrow religious exemptions apply |
Quick Comparison: Ayahuasca Around the World
| Factor | Colombia (Yagé) | Peru (Ayahuasca) | Brazil (Daime/Vegetal) |
| Admixture plant | Diplopterys cabrerana (chagropanga) | Psychotria viridis (chacruna) | Psychotria viridis |
| Healer title | Taita | Curandero / Onanya | Mestre / Guia |
| Ceremony instrument | Harmonica, copal, tobacco | Icaros (sacred songs) | Hymns (hinários) |
| Legal status | Legal, culturally protected | Legal, cultural heritage | Legal since 1987 |
Full Answer
Ayahuasca is a brew prepared from the Banisteriopsis caapi vine combined with DMT-containing plants, most commonly Psychotria viridis in Peru and Brazil or Diplopterys cabrerana in Colombia and Ecuador. The vine contributes beta-carboline alkaloids that act as monoamine oxidase A inhibitors (MAOIs), allowing oral DMT to survive digestion and produce its effects. Ceremonies typically last 4 to 6 hours and are led by trained indigenous healers. The brew travels under many names: yagé, yaje, hoasca, daime, caapi, vegetal, iowaska, ayawaska. Under United States federal law it is a Schedule I controlled substance, with narrow religious exemptions for specific communities.
How to Say It, Spell It, and Understand What It Means
64,000 people a month search for ayahuasca using a spelling that is not quite right. Every one of them is looking for the same thing.
How to pronounce ayahuasca: Ah-yah-WAHS-kah. Four syllables. The “hu” is silent — not “hoo.” In Colombia, the same medicine is called yagé (yah-HEH) or yajé. Common alternate spellings include iowaska, ayawaska, ayahuascha (common in German and Polish-speaking countries), and the phonetic Polish form ajalaska. All of these refer to the same sacred brew. If you arrived here searching for iowaska, ayawaska, ayahuascha, or ajalaska — you are in the right place.
The word itself comes from Quechua, the language of the Andean highlands. Aya means spirit or ancestor. Waska means vine. The vine of the soul. The vine of the dead. Both translations exist, both are accurate, and together they say something true about what this medicine is used for: contact with something that runs deeper than ordinary waking life.
Across the Amazon basin the same brew travels under many regional names: yagé and yajé in Colombia and Ecuador; natema among the Shuar; daime and hoasca in Brazil; caapi among Tupi-Guarani peoples. Each name carries its own tradition. The pharmacology is the same. The worlds it opens are related but not identical.
Ayahuasca and Yagé: The Same Medicine, Different Names
The medicine has one pharmacological engine and dozens of names, each carrying its own tradition.
The word ayahuasca comes from Quechua: aya meaning spirit or ancestor, and waska meaning vine. But walk north into Colombia and the same medicine becomes yagé or yaje. Cross into Ecuador and the Shuar call it natema. Step into a Brazilian church and it is daime or vegetal. Each name is a doorway into a different world, a different history, a different set of relationships between people, land, and plant.
The pharmacological core is constant. Banisteriopsis caapi vine is cooked with a DMT-containing admixture plant. The vine contributes harmine, harmaline, and tetrahydroharmine (THH), beta-carboline alkaloids that shut down monoamine oxidase A (MAO-A) long enough for DMT to survive the gut, enter the bloodstream, and reach the brain. Remove the vine and nothing happens. The vine is not flavoring. It is the key.
What changes between traditions is everything else: which admixture plant, how the vine is harvested, who prepares it, what songs are sung over it, and what the community understands itself to be doing when someone drinks. In Colombia and Ecuador, the admixture plant is typically Diplopterys cabrerana (chagropanga) rather than the Peruvian standard Psychotria viridis. Laboratory analysis confirms that D. cabrerana leaves carry roughly 2.4 mg/g of DMT versus 0.94 mg/g in P. viridis, producing considerably stronger brews by volume (Chambers et al., 2020; Brito-da-Costa et al., 2020). More than 100 botanical species have been documented as additives across different cultural preparations (Schultes, Hofmann & Rätsch, 2001). There is no fixed recipe.
The name yagé carries weight that a pharmacological description cannot hold. Contemporary Siona taita Pablo Maniguaje-Yaiguaje writes and speaks about yajé not as a substance but as a living force, as the medium through which he addresses the Siona Indigenous Guard after ceremony, as an act of resistance and re-existence against armed violence and petroleum extraction eating into Putumayo territory (Langdon, Laffay & Maniguaje-Yaiguaje, 2023). The medicine and the land, in this telling, are not separate concerns. They never were.
Ayahuasca Yagé in Colombia: Mocoa and the Putumayo
The Putumayo is not a location on a map. It is the ancestral ground of the yagé tradition.
If there is a center of gravity for the yagé world, it sits somewhere in the Colombian Putumayo. The department stretches from the Andean foothills down into the lower Amazon basin, and it holds within it a density of indigenous yagé-using peoples that has no parallel anywhere on the continent: Inga, Kamsá, Siona, Cofán, Coreguaje, all within a few hours of each other, all carrying distinct ceremonial traditions refined across centuries.
The town of Mocoa is where many of these worlds intersect. It is a market town, a departmental capital, and also a place where you can sit with a Kamsá taita in the Sibundoy Valley or travel down into Siona territory in a day. Schultes, who spent twelve years walking these forests between 1941 and 1953, called the yagé traditions of the Colombian Amazon among the most sophisticated he had encountered anywhere in the world, a body of botanical and ceremonial knowledge accumulated across an unbroken lineage (Schultes & Raffauf, 1992).
That lineage has survived things most traditions have not. Spanish colonization. The rubber boom, which devastated Cofán and Siona communities across the borderlands in the late nineteenth and early twentieth centuries (Wasserstrom, 2014). Decades of armed conflict. Oil extraction. And now the quieter pressure of ayahuasca tourism arriving with money and insufficient understanding.
UMIYAC, the Union of Traditional Yagé Medics of the Colombian Amazon, formally unites five indigenous groups around shared ceremonial practice and a collective assertion: that this medicine belongs to these peoples and to these territories, and that anyone engaging with it carries a responsibility to that fact. Colombia’s Constitutional Court has recognized multiple Putumayo peoples as at risk of physical and cultural extermination. UMIYAC’s answer to that risk is, in part, the ceremony itself.
Ayahuasca in Peru
Vegetalismo built a whole pedagogy around the idea that plants teach. Shipibo healers built a whole science around icaros.
Peru is where most Westerners first encounter ayahuasca, and it is also where two of the most distinct ayahuasca traditions in the world have developed alongside each other for centuries.
Vegetalismo is the mestizo shamanic practice concentrated around the cities of Iquitos and Pucallpa in the Peruvian Amazon. Its healers, called vegetalistas or curanderos, train by entering into relationship with specific plants through the dieta, long periods of isolation and dietary restriction during which plant spirits are understood to transmit knowledge directly. Luna’s 1984 paper was the first academic treatment to take this epistemology seriously, documenting the phrase la purga misma te enseña, the purgative itself teaches you, as the tradition’s core claim about how learning works (Luna, 1984). The plant is not just the vehicle. The plant is the teacher.
The Shipibo-Conibo tradition runs deeper and older. Shipibo onanyabo (master healers) do not improvise in ceremony. They sing icaros, sacred medicine songs received from plant spirits during years of dieta, each song calibrated to a specific condition, a specific energetic state, a specific person. The ceremony is not ambient. It is diagnostic. The healer reads the room through song and adjusts in real time. A 2021 observational study documented Shipibo-led ceremonies producing significant long-term improvements in psychological well-being across all measured scales at all time points (Gonzalez et al., 2021). That is what precision looks like.
Peru declared ayahuasca a national cultural heritage in 2008. It submitted a reservation for traditional plant use when signing the 1971 UN Convention. These are legal gestures, but they point at something real: a country that has decided this medicine is part of what it is.
Ayahuasca in Brazil
Brazil did not just tolerate ayahuasca. It made it a model for the world.
The story of ayahuasca in Brazil begins with a rubber-tapper from the state of Acre, a man named Raimundo Irineu Serra, who in the early 1930s received what he understood to be a vision from the Rainha da Floresta, the Queen of the Forest, instructing him to found a new spiritual community built around the medicine he had encountered in Amazonian indigenous use. He called what he founded Santo Daime. The name means, roughly, give me.
What Irineu Serra created was something genuinely new: a syncretic tradition that brought together the pharmacological core of indigenous vegetalismo with Afro-Brazilian spiritual practices, Catholic imagery, and the hymnody of Brazilian popular devotion. Participants in Santo Daime ceremonies stand in formation, men on one side, women on the other, and sing prescribed hymns called hinários for hours while drinking daime, the brew. The music is not accompaniment. The music is the structure the ceremony moves through.
Two other traditions grew in parallel. The União do Vegetal (UDV), founded in 1961 by José Gabriel da Costa in the state of Rondônia, built its practice around a more contemplative approach: participants sit in silence between periods of guided meditation, drinking hoasca within a framework that draws on spiritist and esoteric Catholic influences. The Barquinha, founded in 1945 in Acre, is the smallest of the three, combining Afro-Brazilian spiritual elements with Christian practice in ways that are distinct from both Santo Daime and UDV (Labate & MacRae, 2010).
What Brazil did with these traditions is remarkable by any international standard. In 1987, following an anthropological review, the federal agency CONFEN removed ayahuasca from the banned substances list entirely. That decision was formalized and deepened in 2010, when CONAD Resolution No. 1 officially ratified the legitimacy of religious ayahuasca use, established ten ethical principles for ceremonial practice, and mandated compliance across all public administration bodies (CONAD Resolution No. 1, 2010). Ayahuasca is legal in Brazil. Not in a grey area. Not under a narrow exemption. Legal, regulated, respected.
The reverberations of that decision have traveled far. When the União do Vegetal in the United States went to the Supreme Court in 2006 to fight for their right to use hoasca in ceremony, they won. When courts in the Netherlands, Spain, and elsewhere have been asked to consider similar questions, Brazil’s regulatory model has been cited as evidence that a thoughtful, principled approach to governance of these medicines is possible (Labate & Feeney, 2012). What began in Acre with a rubber-tapper’s vision has become, in its way, a legal template for the world.
Ayahuasca in Ecuador
The Shuar call it natema. The Cofán call it yajé. The plants and the vine know no borders.
Ecuador sits at a geographic crossroads of the ayahuasca world. Its Amazon basin connects to both the Colombian Putumayo traditions to the north and the Peruvian vegetalismo traditions to the south, and the country’s indigenous ayahuasca-using peoples have developed in relationship with both.
The Shuar (Jivaroan) of the Ecuadorian lowlands call the medicine natema and have used it within an elaborate shamanic system focused on the acquisition and defense of arutam power, spiritual force transmitted through visionary experience that is understood to protect against violence and misfortune. The Shuar relationship to the medicine is specifically about power and its management, a framework quite different from the Colombian emphasis on community healing or the Peruvian emphasis on the healer’s diagnostic function.
The Colombia-Ecuador borderlands are also Cofán and Siona territory, and the yajé traditions of these peoples cross the political border without interruption. Shared lineages, shared songs, shared botanical knowledge. What maps call two countries, the medicine does not recognize (Wasserstrom, 2014).
As in Colombia, the admixture plant used in Ecuadorian preparations is primarily Diplopterys cabrerana rather than Psychotria viridis, producing the distinctly different alkaloid profiles and ceremonial characteristics associated with the northern traditions (Brito-da-Costa et al., 2020). The globalization of ayahuasca has brought urgent questions to Ecuador about intellectual property, biopiracy, and what it means when a tradition becomes a commodity (Tupper, 2009).
The Colombian Tribes: Inga, Kamsa, Kofan, Siona
These are not four separate traditions arranged around the same brew. They are four distinct cosmological systems that share a plant.
They live within a few hours of each other in the Colombian southwest, their territories overlapping in the Putumayo lowlands and the Sibundoy Valley, and yet they are not the same people with the same practice. They are different nations with different languages, different cosmologies, and different understandings of what yagé is and what the ceremony does.
The Inga and Kamsá (Kamentsá) of the Sibundoy Valley have occupied the only flat highland valley in all of Colombian Amazonia for as long as anyone can trace. Their taitas maintain yané (yagé) gardens of extraordinary botanical complexity and undergo multi-year initiations through successive visionary experiences under the guidance of more senior healers. For centuries they have served as intermediaries between the highland Andean world and the Amazonian lowlands, moving between both and bringing knowledge from both into their practice (Ramírez de Jara & Pinzón Castaño, 1993).
It was an Inga man, Miguel Evanjuanoy Chindoy, spokesperson of UMIYAC, who co-authored the Lancet paper establishing eight ethical principles for Western researchers approaching indigenous yagé medicine. Those principles, including reverence, responsibility, and reparation, are not diplomatic gestures. They are an Inga leader stating clearly what indigenous communities expect from the Western world that has arrived at their door (Celidwen et al., 2022).
The Siona of the Putumayo lowlands are among the most extensively documented ayahuasca-using peoples in the world, largely because of the anthropologist E. Jean Langdon, who has been conducting fieldwork with them since the 1970s. What she found, and what five decades of returning has confirmed, is a tradition that is not static. When Siona shamanism appeared to have nearly died out by the early 1970s, it revitalized, driven by the emergence of transnational indigenous networks and the Siona’s own strategic assertion of identity (Langdon, 2016). Traditions that look fragile from the outside have their own forms of resilience.
The Cofán (A’i Kofán) straddle the Colombia-Ecuador border. Their curaga (shaman) acquires power not through study in any Western sense but through years of surrender to nonhuman agents encountered in yajé, a process that is understood to make the healer both necessary and dangerous to the community. The Cofán are explicit that their shamanic knowledge cannot legitimately leave proper lineage, and they have been explicit in challenging organizations that claim otherwise (Cepek, 2019; Jütte, 2018).
Peruvian and Amazonian Tribes: Shipibo, Yawanawa, and Others
The Shipibo did not just use ayahuasca. They built a whole system of diagnosis, treatment, and knowledge transmission around it.
Walk into a Shipibo ceremony and you will notice, eventually, that the healer is not just singing. She is reading. The icaros she sings are not a playlist. They are a real-time response to what she perceives in the room: the energetic state of each participant, where the medicine is moving, what needs to be addressed. The onanyabo (master healer) receives these songs through years of dieta with specific plant teachers, each plant transmitting its own repertoire, its own range of treatment. The healing system is structured, cumulative, and precise (Gonzalez et al., 2021; Luna, 1986).
This is why working with an authentic Shipibo healer is a different experience from working with someone who has learned a few icaros from YouTube. The songs only work when they come from the relationship that generated them.
The Yawanawa of Acre, Brazil, were nearly destroyed by rubber extraction and forced assimilation in the twentieth century. Their revival since the 1990s has been remarkable: a strategic building of alliances with Santo Daime, with urban non-indigenous Brazilians, with international visitors, using ayahuasca alongside rapé, sananga, and other forest medicines as the medium through which cultural knowledge passes from elders to younger generations and from the Amazon to the wider world (de Rose, 2024).
The Huni Kuin (Kaxinawa), Ashaninka, and the Tukano peoples of the northwest Amazon each hold distinct ayahuasca traditions. Among the Desana, a Tukanoan people of the Colombian Vaupés, the anthropologist Gerardo Reichel-Dolmatoff documented in the 1970s something that challenges every reductive account of what yajé is: the visions are not random. They are a culturally encoded symbolic system through which shamans negotiate energy flows between humans, animals, and supernatural forces. The medicine, in this cosmology, is the epistemological engine of ecological and social regulation (Reichel-Dolmatoff, 1971). The ceremony is governance.
The Healer, the Taita, and the Icaros
The brew does not conduct itself. The healer is the container, the diagnostician, and the guide.
A title is not a credential. In Colombia the word taita means father, and it carries specific weight: it is not self-assigned but conferred by a community that recognizes years of training, demonstrated healing ability, and accountability to tradition. In Peru, curandero or Shipibo onanya points to a similar thing: someone who has done the work and been recognized for it. In Brazil the mestre or guia has trained within a lineage structure that includes both pharmacological knowledge and spiritual responsibility. These titles are not interchangeable and they are not for sale.
What the training involves is, in every case, long and serious. Among the Inga and Kamsá, initiation unfolds over years, successive yagé experiences under senior taita guidance building a body of visionary knowledge that cannot be rushed (Ramírez de Jara & Pinzón Castaño, 1993). Among the Shipibo, the primary pedagogy is the dieta: periods of isolation, dietary restriction, and sexual abstinence during which the healer lives alone with specific plant teachers and receives icaros directly from plant spirits. Berlowitz et al. (2022) documented, through interviews with sixteen Peruvian healers, that the dieta is actually more commonly practiced than ayahuasca alone in remote Amazonian communities. The dieta is not preparation for the real work. The dieta is the real work.
The icaros are the healer’s primary instrument in ceremony. They are not decoration and not atmosphere. Dobkin de Rios and Katz (1975) were the first to document systematically what everyone present in a ceremony can feel: the healer’s whistled or sung icaros directly shape and direct the psychedelic experience. Faster incantations move people deeper; slower melodies stabilize and guide. In a 2023 study at the Takiwasi Center in Peru, every single rehabilitation patient in the study reported that icaros changed their psycho-emotional state and facilitated healing (Graham et al., 2023). One hundred percent.
Beyond the icaros, a skilled healer brings other plant allies into the ceremonial space. Bobinsana (Calliandra angustifolia) is a heart-opening Amazonian plant used in many healing traditions for its gentle, emotionally softening qualities — often incorporated into the healer’s own dieta to deepen empathy and energetic sensitivity. Tobacco — mapacho — is used throughout the ceremony for protection, cleansing the space, and grounding what moves. The taita’s tobacco is not recreational. It is a tool. Toé (Brugmansia) and rapé are also used by experienced practitioners at key moments to shift energetic states or steady what is moving in the room. These plant allies are not extras. They are part of how a real ceremony works.
The distinction between a trained lineage holder and someone who has attended a three-week facilitator program and hung out a shingle matters more than almost any other single factor in determining what a ceremony will actually be.
Types of Ayahuasca Medicine: Quality Matters
Potency varies plant to plant, batch to batch, and preparation to preparation. What you receive is not a standardized product.
Ayahuasca is not a pharmaceutical with a standardized dose on the label. Chemical analysis of 32 Banisteriopsis caapi samples from 22 Brazilian sites found alkaloid distribution ranging widely across all samples. DMT levels in Psychotria viridis samples varied so considerably that some contained little or no detectable DMT at all (Callaway, Brito & Neves, 2005). What this means in practice is that the medicine you drink in one ceremony can be pharmacologically very different from what you drink in another, even if the same general preparation was used.
Crudo: The Freshest Ayahuasca Yagé
Crudo is the freshest ayahuasca yagé that exists. Uncooked, unpasteurised, prepared from vine harvested and processed the same day, it is as close to the living plant as the medicine ever gets.
Because it is not cooked, crudo is considerably easier on the body than cooked medicine. The taste, while still unmistakably the medicine, does not carry the dense bitterness of a long-reduced brew. For many people arriving at ceremony for the first time, it is significantly more forgiving on the digestive tract. For those with higher sensitivity to the medicine, it is often the better form.
What can be said scientifically is that alkaloid concentrations shift significantly depending on harvesting season, plant maturity, soil conditions, and preparation method. Crudo is not inherently weaker than cooked medicine. At higher doses it can be every bit as powerful. What it offers is a different quality of entry, one that many experienced practitioners consider the best starting point for those new to the tradition.
Crudo is only available in Colombia. Because it is not cooked, it ferments quickly and cannot be transported or stored. You drink it where it is made, within days of preparation. That limitation is also what makes it rare. Outside of Colombia, no one is offering genuine crudo.
MahaDevi is the only ayahuasca retreat that offers both cooked and crudo medicine to its participants, allowing each person to meet the medicine in the form that serves them best. It is a genuinely unique experience.
Cooked Medicine
Traditional ceremonial medicine is cooked over many hours, sometimes across multiple days, reducing the liquid down and concentrating the active alkaloids. This is the most common form in established ceremonial contexts worldwide.
That the tradition of careful preparation runs deep is not in question: LC-MS/MS analysis of a shamanic bundle from Cueva del Chileno in Bolivia, approximately 1,000 years old, detected both harmine and DMT as co-present compounds, the first direct archaeological evidence that the key ingredients of an ayahuasca-like preparation were being intentionally combined by a pre-Columbian shaman (Miller et al., 2019). The sophistication was already there.
Ayahuasca Paste
Paste preparations, sometimes called pasta de yagé, are what most people drink when they attend an ayahuasca retreat in Florida, California, Costa Rica, or anywhere outside Amazonian territory. The simple reason: you cannot ship fresh or cooked medicine across borders. Paste is what survives the journey. The brew is cooked down into a concentrated solid form, then reconstituted with water for ceremony.
It works. For many people who cannot access fresh or traditionally prepared medicine, it is a reasonable and practical choice. But it is worth being honest about what it is.
Think of it like taking a high-quality wine, reducing it to a paste, and then adding water back before serving. The core compounds are present. Something of the original has been preserved. But the freshness, the full spectrum of volatile compounds, the quality that made it exceptional in the first place — those things do not survive the process intact. Paste medicine is considered by many traditional practitioners to be less medicinal than crudo or properly cooked medicine precisely because of what is lost in that reduction.
Paste allows for more consistent dosing and easier transport across territory, which is why it has become the dominant format in the global retreat industry. For those who have no access to high-quality fresh medicine, it is an acceptable starting point. For those who have a choice, most people who have drunk both know which one they prefer.
Ayahuasca vs Other Plant Medicines
The comparisons are useful only if the underlying pharmacology is understood first.
Ayahuasca vs Psilocybin Mushrooms
Both ayahuasca and psilocybin activate serotonin 5-HT2A receptors, which is why they share a family of effects: visual phenomena, shifts in sense of self, emotional depth, and in controlled settings, therapeutic potential. But they are not interchangeable. The most important practical difference is MAOI activity: ayahuasca’s beta-carboline alkaloids create significant drug interaction risks that psilocybin mushrooms simply do not have. If you take SSRIs, this difference is not academic. A 2023 meta-analysis found psilocybin showed the largest effect size for depression (Hedges’ g = -1.92) among major psychedelics studied, with ayahuasca also showing significant antidepressant effects (Bahji et al., 2023). Both work. They work differently.
Ayahuasca vs Ibogaine
Ibogaine operates through a completely different pharmacological mechanism, acting on kappa-opioid and sigma-2 receptors rather than primarily via 5-HT2A. The experiential difference is stark: ibogaine can last 24 to 36 hours, runs through what many people describe as a relentless confrontation with life history, and carries cardiac risks (QT prolongation) that require medical screening more intensive than ayahuasca. A landmark 2024 study from Stanford found that magnesium-ibogaine treatment produced rapid, significant improvements in PTSD, depression, and anxiety in U.S. Special Operations veterans with traumatic brain injuries (Cherian et al., 2024). It is a different tool for different work.
Ayahuasca vs San Pedro / Mescaline
Both ayahuasca and San Pedro cactus (Trichocereus pachanoi) activate 5-HT2A receptors, but they belong to different chemical families. DMT is a tryptamine. Mescaline is a phenethylamine, structurally closer to dopamine than to serotonin. San Pedro ceremonies are typically daytime, grounded, and oriented toward the land rather than inward into the dark. Neither produces physical dependence (Doesburg-van Kleffens et al., 2023). They are not versions of the same thing. They are related medicines with different characters.
The Ayahuasca Ceremony
The ceremony is not the container for the medicine. In every tradition, the ceremony is part of the medicine.
Before the first cup, there is already ceremony. The setting up of the space, the placement of the fire, the opening of protective intention, the instructions given to participants. None of this is preamble. It is already the medicine working through the people who are holding it. A plant medicine ceremony is not an event you attend. It is a process you enter.
In the Shipibo tradition, the ceremony unfolds through icaros, the healer’s sacred songs. The onanya opens with diagnostic songs, reads each participant’s energetic state, and works through a carefully sequenced progression of healing songs from opening to close. Participants lie on mats. The space is dark or near-dark. The medicine moves inside the container the icaros create (Gonzalez et al., 2021).
In the Colombian Taita tradition the ceremony breathes differently. There is the harmonica, the sacred fire, limpieza with copal smoke, tobacco used for protection and cleansing, Agua Florida, plant essences, rapé blown into the nostrils to shift or steady what is moving. Moments of shared song alternate with silences that have weight. The taita moves through the room, working individually and collectively, the sonic toolkit serving simultaneously as protection, healing technology, and communal anchoring (García Molina, 2014).
In Santo Daime ceremonies, participants stand in formation and sing prescribed hymns called hinários for hours, moving between sitting and standing, women and men in their respective formations. The structure is more explicit, more communal, and physically more demanding than either the Shipibo or Taita forms. The hymns are understood to be channeled transmissions from spiritual forces, not composed by human hands.
Many people searching for an ayahuasca ceremony near me, or for a plant medicine ceremony closer to home, eventually find their way to the question of what a genuine ceremonial container actually requires. The answer, consistently, is a trained lineage holder, a properly held space, and community. A survey of 6,877 international ayahuasca drinkers confirmed what any experienced participant already knows: mystical experience strength, self-insights during the session, and community support afterward were all positively associated with mental health outcomes. Acute extreme fear and difficulty integrating the experience afterward were the variables most associated with harm (Perkins et al., 2021). Set and setting is not a suggestion. It is a mechanism.
Mother Ayahuasca — The Intelligence of the Medicine
Across every tradition, the medicine is understood as more than a compound. It is understood as a presence.
Benny Shanon, a cognitive psychologist at the Hebrew University, spent years systematically documenting ayahuasca phenomenology across more than 2,500 sessions and interviews with indigenous people, shamans, and participants from many backgrounds. What he found was not random: consistent, cross-cultural encounters with what people described as nonhuman presences, guiding intelligences, something that felt older and wiser than the person drinking (Shanon, 2002).
Gearin’s (2024) more recent anthropological work confirmed that the concept of ayahuasca as a sentient plant teacher — Madre Ayahuasca, Mother Ayahuasca — runs across Shipibo shamans, secular Westerners, and everyone in between. Animists interpret this literally. Secular drinkers interpret it metaphorically. Both are having the same experience. In traditional Amazonian cosmology, Mother Ayahuasca is understood as a grandmother intelligence, a feminine healing force that meets each person exactly where they are. The medicine knows what it is doing. That is not mysticism performing. That is what thousands of documented sessions consistently report.
The concept of ayahuasca spiritual awakening — an opening to dimensions of experience that feel larger than ordinary selfhood — is central to why people travel from every corner of the world to sit in ceremony. It is also why the container matters so much. This level of opening requires holding.
Preparation: Diet, Dieta, and Mindset
The dieta is not merely preparation for ayahuasca. In traditional Amazonian medicine, it is itself a complete healing technology.
Most people think of preparation as the things you do before the ceremony. In traditional Amazonian medicine, that framing misses something important.
The pharmacological requirement is real and non-negotiable. Ayahuasca’s beta-carboline alkaloids inhibit MAO-A, the enzyme that normally breaks down serotonin and dietary tyramine. With MAO-A inhibited, certain foods and medications your body would ordinarily process safely can accumulate to dangerous levels. This is not theoretical.
The dietary concerns are practical: tyramine-rich foods including aged cheeses, cured and fermented meats, soy sauce, and overripe fruit should be avoided for at least 24 to 48 hours before ceremony. The medication concerns are more serious. Combining ayahuasca with SSRIs, SNRIs, MAOIs, MDMA, amphetamines, tryptophan, or other serotonergic substances carries real risk of serotonin syndrome, a medical emergency. This combination is contraindicated regardless of whether you feel ready to stop your medication (Callaway & Grob, 1998; Ruffell et al., 2020). If you take anything affecting serotonin, tell your provider before you agree to attend.
Any provider who does not ask about your medications in detail is not a safe provider.
The traditional dieta goes further. O’Shaughnessy and Berlowitz (2021) position it not as preparation for ayahuasca but as a standalone healing technology: periods of isolation, dietary restriction, and sexual abstinence during which specific plant teachers are ingested and their knowledge absorbed. Among the sixteen Peruvian healers interviewed by Berlowitz et al. (2022), the dieta was described as more commonly practiced than ayahuasca alone in remote communities, and as going deeper in its restructuring effects than the ceremony itself. What this means for a participant approaching a single retreat is simpler: how you prepare is not separate from what you receive. The work has already started.
If you are preparing for ayahuasca and want to understand what responsible preparation actually looks like, the Ayahuasca Framework at mahadeviayahuasca.com/education is a free course built around these questions — from pharmacology to mindset to what to ask your facilitator.
The Ayahuasca Experience
What happens depends as much on the container as on the brew. The research describes tendencies, not guarantees.
Onset arrives somewhere between twenty minutes and an hour after drinking. The body announces it first: warmth moving through the chest, a shift in the quality of sound, colors beginning to carry more weight than usual. Then the medicine opens.
DMT activates serotonin 5-HT2A receptors in the brain, producing the cascade of perceptual, emotional, and cognitive shifts that make this medicine unlike anything else. Perkins et al. (2023) identified five core psychotherapeutic processes in the ayahuasca experience: somatic effects, introspection and emotional processing, increased self-connection, increased spiritual connection, and the gaining of new insights and perspectives. The somatic dimension — enhanced body awareness, interoception, and the purge itself — is something ayahuasca does more intensely than any other psychedelic.
The purge, or la purga, is worth speaking about directly because it frightens people who have not yet done ceremony and confuses those who approach it through a purely biomedical lens. Politi et al. (2022) mapped the pharmacological mechanism: beta-carboline alkaloids activate 5-HT3 receptors in the chemoreceptor trigger zone and vagal pathway, producing emesis. That is what is happening in the body. In the ceremony, what most participants report is something harder to measure: a sense that what is leaving is not just dinner. The purge creates space. It is part of what the medicine does, not a side effect of it.
Ayahuasca experiences last four to six hours in most cases. In a double-blind pharmacokinetic study, all tested doses produced dose-dependent increases in blood pressure (peak +13.8 mmHg systolic) and heart rate (+9.2 bpm), resolving within four hours (Riba et al., 2003). The physical cardiovascular effects are real and relevant for anyone with heart conditions.
DMT, Neuroplasticity, and How It Works
The vine solves a problem that DMT alone cannot: it makes oral activity possible through a pharmacological partnership that neither plant achieves alone.
This section contains medical and pharmacological information. It is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider regarding any personal medical decisions.
DMT, dimethyltryptamine, is present in Psychotria viridis and the other admixture plants used in ayahuasca. It is also, notably, present in the human body. Taken orally as an isolated compound, it is destroyed by MAO-A in the gut and liver before it can reach the brain. You could eat pure DMT and nothing would happen. The Banisteriopsis caapi vine solves this through its beta-carboline alkaloids: harmine, harmaline, and THH. These alkaloids reversibly inhibit MAO-A, creating a window during which DMT can survive digestion, enter the bloodstream, and cross into the brain (Egger et al., 2024). Remove the vine and the whole system fails. The vine is not an adjunct. The vine enables everything.
Once in the brain, DMT acts primarily through serotonin 5-HT2A receptors, with additional actions at 5-HT1A, 5-HT2C, and sigma-1 receptors. The synergistic effects of DMT and MAOIs together appear to promote neuroplasticity, the brain’s capacity to form new connections, reorganize existing ones, and operate with greater flexibility. This is the current leading hypothesis for why ayahuasca produces lasting therapeutic changes rather than simply a temporary altered state (Egger et al., 2024; Rossi et al., 2022). The brain comes out of the experience physically different from how it went in.
A 2020 fMRI study measured what this looks like neurologically. Twenty-four hours after ayahuasca, participants showed increased connectivity in the anterior cingulate cortex within the salience network, associated with emotional self-regulation, and decreased connectivity in the posterior cingulate cortex within the default mode network, the brain’s resting rumination system (Pasquini et al., 2020). That default mode network suppression is thought to be central to why ayahuasca can interrupt the loops of depressive thinking and traumatic re-experiencing that conventional antidepressants struggle to touch.
Inserra (2018) proposed a more specific mechanism for the trauma piece: DMT’s activation of the sigma-1 receptor, combined with beta-carboline MAO inhibition, may allow the retrieval of repressed traumatic memories into a neuroplastic state where they can be processed rather than simply re-experienced, enabling fear extinction and memory reconsolidation. This remains a hypothesis, but it is grounded in known pharmacology and it matches what many participants and clinicians describe observing.
Ayahuasca for Mental Health: Depression, PTSD, and Addiction
The evidence base is growing, the effect sizes are large, and the caveats are real.
This section discusses emerging clinical research on ayahuasca. It is educational only. Ayahuasca is not an approved medical treatment in any country. Nothing here constitutes medical advice. Consult a qualified healthcare provider before making any decisions related to mental health treatment.
The clinical research on ayahuasca is young, but some of its numbers are striking. In 2019, a randomized placebo-controlled trial administered a single dose of ayahuasca to twenty-nine patients with treatment-resistant depression, people for whom multiple conventional antidepressants had already failed. At Day 7, response rates were 64% in the ayahuasca group versus 27% in placebo, at a between-group effect size of Cohen’s d = 1.49 (Palhano-Fontes et al., 2019). That is a large effect by any clinical standard, and it was achieved in one dose.
A 2024 meta-analysis across 126 studies found ayahuasca produced a large therapeutic effect on depression and anxiety (Hedges’ g = -1.34), placing it among the most effective psychedelics studied (Yao et al., 2024). A systematic review through 2022 found consistent evidence of beneficial effects on depression, anxiety, substance use disorders, and PTSD across clinical trials, observational studies, and survey-based investigations (Duarte et al., 2023).
For addiction: a study of 1,947 UDV members, regular ceremonial ayahuasca users from ten Brazilian states, found current alcohol and tobacco use disorder rates significantly lower than Brazilian national norms. Years of membership and ceremony attendance were significant predictors of disorder reduction (Barbosa et al., 2018). This is a long-term, large-scale natural experiment.
A naturalistic longitudinal study found that one month after ayahuasca ceremony, participants showed significant reductions in depression, anxiety, stress, alcohol and cannabis use, body dissociation, and impulsivity, alongside significant increases in positive mood, self-efficacy, authentic living, and spirituality (Pagni et al., 2022). These were not subtle changes.
The caveats need to be stated clearly. Most studies are small. Blinding is difficult because the experience is distinctive. Evidence certainty is currently rated low to very low by systematic review standards. The research is genuinely promising. It does not yet constitute sufficient evidence to recommend ayahuasca as a medical treatment, and anyone who tells you otherwise is overstating what the science currently supports.
Ayahuasca Integration: After the Ceremony
The ceremony opens something. Integration is the work of understanding what opened and what to do with it.
The morning after ceremony, people sometimes feel cracked open. Sometimes they feel flat. Sometimes they have no idea what happened but know that something did. Sometimes they surface with a specific insight so clear it feels carved. All of these are valid starting points for the harder work.
Among 1,630 ayahuasca drinkers surveyed globally, integration was described not as a structured post-session therapy appointment but as a long, sometimes messy, fundamentally communal process. Many participants found that the clinical model of individual psychotherapy as the primary integration container did not match their actual experience (Cowley-Court et al., 2023). What helped was human: conversations with others who had been through something similar, time in community, and support that honored the non-ordinary nature of what had happened rather than trying to translate it immediately into psychological categories.
Watts and Luoma (2020) proposed the ACE model, drawn from Acceptance and Commitment Therapy, as a framework for integration: Accept the experience as it was. Connect with what matters. Embody the change in how you actually live. Gorman et al. (2021) introduced the first transtheoretical clinical model for integration as a standalone practice, applicable regardless of what context someone used psychedelics in. These frameworks are useful. They are not substitutes for the community dimension.
The numbers support this. In 6,877 international ayahuasca drinkers, integration difficulties were negatively associated with mental health outcomes. Community support and self-insights during the session were positively associated (Perkins et al., 2021). The ceremony is one event. The integration is the longer arc. Many people take more time with integration than they spent preparing.
Practically: journaling in the days following ceremony, movement and somatic practices, time in nature, honest conversations with people who understand the territory. If the experience raised clinical material, professional support from a therapist familiar with non-ordinary states of consciousness. Richards’ (2015) framework for understanding mystical experience, developed through nearly thirty years of research at Johns Hopkins, remains one of the most useful orientations for working with what cannot easily be put into language.
Legal Status of Ayahuasca
The brew itself is not scheduled internationally. The compound it contains is. The distinction matters.
This section contains legal information for educational purposes only. Laws change and vary by jurisdiction. Nothing here constitutes legal advice. Consult a qualified attorney for guidance specific to your situation.
Here is the distinction most people miss: the 1971 UN Convention on Psychotropic Substances placed DMT in Schedule I. It did not schedule plants or plant-based preparations. The International Narcotics Control Board has clarified this position formally: ayahuasca plants and preparations are not under international control under the convention (UNODC, 1971; Sánchez Avilés & Rebollo, ICEERS, 2019). What individual countries do with that fact is their own business, and they have made very different decisions.
In the United States: DMT is a Schedule I controlled substance under federal law (DEA, 2024). Ayahuasca as a brew is illegal at the federal level. The only carve-out comes from the Supreme Court’s 2006 unanimous ruling in Gonzales v. O Centro Espírita Beneficente União do Vegetal, which held that the government had not demonstrated a compelling interest sufficient to override the UDV’s religious freedom under the Religious Freedom Restoration Act. That ruling protects the UDV specifically. It does not protect you, a retreat operator, or anyone else operating outside that specific religious context.
In Brazil: legal for religious use since 1987, formalized in 2010. In Peru: declared national cultural heritage in 2008, legal for traditional use. In Colombia: legal and culturally protected for indigenous communities, with general use occupying a grey area that is rarely enforced.
In most of Western Europe, ayahuasca is illegal under domestic drug laws. France and Russia are straightforwardly prohibitionist. Portugal, Mexico, Israel, and Spain maintain legal ambiguity: not explicitly legalized, not actively prosecuted (Rebollo & Sánchez Avilés, ICEERS, 2019).
Colorado’s Proposition 122 (2022) decriminalized personal possession and use of DMT among five natural psychedelic substances and created a framework for licensed healing centers eligible to offer DMT sessions beginning June 2026 (Colorado Natural Medicine Health Act, 2022). This changes state enforcement. It does not change federal law.
Ayahuasca Safety: Risks, Dangers, and Who Should Avoid It
The most preventable serious harms involve drug interactions. Know your medications before you consider the ceremony.
This section contains medical and safety information. It is for educational purposes only and does not constitute medical advice. If you take any medication or manage a health condition, consult a qualified healthcare provider before making any decisions related to ayahuasca.
The honest safety picture sits between two distortions. One frames ayahuasca as a dangerous hallucinogen that sends people to emergency rooms. The other, common in retreat marketing, presents it as reliably healing and implicitly safe for everyone. Neither is accurate.
Ayahuasca carries an acceptable safety profile in healthy populations when used in controlled settings with experienced facilitators and rigorous pre-screening. Serious adverse events in otherwise healthy individuals are rare. The most common effects, nausea and vomiting, are expected and culturally framed as therapeutic. Less common are transient anxiety, headaches, and temporary blood pressure increases.
Drug interactions are the most preventable category of harm. Ayahuasca’s beta-carboline alkaloids inhibit MAO-A, which normally processes serotonin and related compounds. When MAO-A is inhibited, SSRIs, SNRIs, MAOIs, MDMA, amphetamines, tryptophan, St. John’s wort, triptans, dextromethorphan, and lithium can accumulate to dangerous levels (Callaway & Grob, 1998; Ruffell et al., 2020; Malcolm & Lee, 2018). A documented case of serotonin syndrome has been recorded with fluoxetine and ayahuasca. The interaction risk is established enough that these combinations are contraindicated regardless of whether a case has been documented in your specific context.
Contraindications:
- SSRIs, SNRIs, or MAOIs: serious interaction risk, potentially life-threatening
- History of schizophrenia, psychosis, or bipolar disorder with psychotic features
- Personal or family history of psychotic or manic disorders: strongly recommend screening
- Cardiovascular conditions or serious hypertension: require medical clearance before attending
- Liver conditions: particularly relevant given MAOI-mediated metabolic load on the liver
- Pregnancy: contraindicated
- Epilepsy: contraindicated
On psychiatric risk: psychotic episodes associated with ayahuasca are rare (estimated 0.0032 to 0.096% of UDV servings), but in most documented cases the person had a personal or family history of psychotic or manic disorders. Psychiatric screening significantly reduces risk (dos Santos et al., 2017).
Ayahuasca does not produce physical dependence. It does not produce tolerance. These are not contested findings (ICEERS, 2024).
Risks are substantially reduced by working with a healer who has genuine training and lineage, providing complete and honest health information to your provider, and choosing a context that includes serious pre-screening. The ceremony does not have to be a gamble.
For a complete guide to preparation, screening, and choosing a trustworthy facilitator, the Ayahuasca Framework at mahadeviayahuasca.com/education covers what responsible preparation actually looks like, from pharmacology to practitioner selection.
How to Choose the Best Ayahuasca Retreat
The container matters more than the setting. The healer matters more than the location.
The global ayahuasca retreat industry has grown enormously since the early 2000s. What began as a handful of indigenous community experiences has expanded into a market with hundreds of retreat centers operating across South America, Europe, and North America. That expansion has created enormous variation in quality, safety, and cultural integrity (Fotiou, 2020). The beautiful website and the compelling testimonials tell you nothing about whether the person holding ceremony has the training and accountability that training requires.
What to Look For in the Best Ayahuasca Retreat
Thorough medical screening is the non-negotiable baseline. Any retreat that asks serious questions about your current medications, psychiatric history, cardiovascular health, and pregnancy status is meeting minimum due diligence (Rossi et al., 2023; ICEERS, 2019). Any retreat that does not is telling you something important about how they approach risk.
Ask about the healer’s lineage. Not their biography. Their lineage. Who did they train with? For how long? What community recognizes them? How are they accountable to the tradition they are offering? There is no credential that substitutes for genuine roots, but there are questions that distinguish someone with real training from someone with a well-designed website.
Ask about emergency protocols. What happens if someone has a medical crisis? Is there someone medically trained present or on call? What is the evacuation plan? These are not anxious questions. They are the questions a thoughtful adult asks before putting themselves in a vulnerable state in the care of another person.
Ask about integration support. What is offered before ceremony to prepare, and what is offered after to support the work that follows? A ceremony without integration support is structurally incomplete.
Ayahuasca Retreat Cost — What to Expect
Ayahuasca retreat cost spans a wide range. Community-based ceremonies in indigenous territories sometimes ask for a modest contribution or donations. Internationally marketed retreat centers in Peru, Colombia, and Costa Rica can charge $1,000 to $6,000 or more per week (Londoño, New York Times, 2020). Price is not a reliable signal of quality in either direction. Some of the most carefully held ceremonies happen in modest settings. Some of the most expensive retreats are thin on accountability and deep on aesthetics.
What you are actually paying for when the pricing is fair: the healer’s knowledge and time, the physical space and logistics, the support staff, the pre-ceremony screening process, and the integration resources. When any of those elements is absent or underbuilt, the price reflects something less than what it claims.
Why Colombia Over Florida, California, USA, or Costa Rica
Many people begin their search for the best ayahuasca retreat looking at options closer to home — an ayahuasca retreat USA, ayahuasca retreat Florida, California, or Costa Rica. These options exist, and for some people they are a starting point. But most of what is offered in those contexts uses paste medicine, is held by practitioners without deep indigenous lineage, and operates in legal grey areas that carry their own risks. The reason is simple: you cannot bring fresh or properly cooked medicine from the Amazon to Florida or California. What arrives is paste. What gets served is a reconstituted version of the real thing.
MahaDevi works in Colombia for specific reasons. The Putumayo and Sibundoy Valley contain some of the oldest unbroken yagé lineages in the world. Taitas trained within Inga, Kamsá, Siona, and Cofán traditions have carried ceremonial practice across colonization, conflict, rubber extraction, and fifty years of armed violence. They are not offering a reproduced tradition. They are offering the thing itself.
Working in Colombia also means working within a legal and cultural context that formally recognizes and protects indigenous ceremonial medicine. The medicine has a home here. The people who hold it have rights that are formally recognized, even if often inadequately enforced. That context matters for the integrity of what you participate in. And at MahaDevi, you have access to both cooked and crudo medicine on ancestral land — something no retreat outside Colombia can offer.
Frequently Asked Questions
Ayahuasca has an acceptable safety profile in healthy people who have been properly screened and are working with an experienced healer in a controlled setting. Serious adverse events are rare in those conditions. The most common effects are nausea and vomiting, which traditional frameworks understand as therapeutic. The most preventable serious risks involve drug interactions, particularly with SSRIs, SNRIs, and other serotonergic medications, and psychiatric contraindications in people with personal or family histories of psychosis or mania (dos Santos et al., 2017; ICEERS, 2024). If you are healthy and properly screened, the risk profile is manageable. If you skip the screening, it is not. Most ayahuasca ceremonies last four to six hours from the time of drinking. Onset arrives twenty to sixty minutes after ingestion. Peak effects typically run from roughly sixty to one hundred and fifty minutes. The full experience, including the gradual return to ordinary consciousness, generally resolves within four to six hours, though some people feel residual shifts in perception and mood into the following day (Riba et al., 2003). Ceremonies are typically held at night and run until the early morning hours. Ayahuasca produces profound shifts in perception, emotion, and sense of self. Common experiences include vivid visionary states, intense emotional processing, physical purging, encounters with what participants describe as plant intelligence or guiding presences, and deep introspective states that can move through grief, fear, gratitude, and clarity in rapid succession. Shanon’s (2002) systematic phenomenological study documented consistent cross-cultural patterns: the experience is not random. Many people describe it as the most meaningful experience of their lives. Many people also find it genuinely difficult. Both of these things are true at the same time. Legality depends on where you are. Ayahuasca is legal for religious use in Brazil, recognized as national cultural heritage in Peru, and legally protected for indigenous use in Colombia. In the United States, DMT is a Schedule I controlled substance. The Supreme Court’s 2006 ruling in Gonzales v. O Centro Espírita Beneficente União do Vegetal granted narrow religious protection to the UDV specifically. That protection does not extend to individuals or retreat operators operating outside that specific religious context. Most of Western Europe prohibits it. Colombia and Peru are the most accessible legal destinations for ceremony (Sánchez Avilés & Rebollo, ICEERS, 2019; DEA, 2024). No. This is the most important safety question in this article. Ayahuasca’s beta-carboline alkaloids inhibit MAO-A, the same enzyme that MAOI antidepressants target. Combining them can produce dangerously elevated serotonergic activity, including the risk of serotonin syndrome, a potentially serious medical emergency. SSRIs and SNRIs also interact dangerously with ayahuasca’s MAOI compounds (Callaway & Grob, 1998; Ruffell et al., 2020). If you take any medication affecting serotonin, consult a physician before any involvement with ayahuasca. Disclose all medications to any provider. This is not negotiable and not something to work around. They are the same medicine with different names carried by different traditions. Yagé is the name used primarily in Colombia and parts of Ecuador, by the Siona, Inga, Kamsá, Cofán, and related peoples. Ayahuasca is the Quechua name used in Peru, Bolivia, and parts of Ecuador. In Brazil the same medicine is called daime in Santo Daime communities and hoasca or vegetal in the União do Vegetal. The key pharmacological difference in many Colombian and Ecuadorian preparations is the use of Diplopterys cabrerana (chagropanga) as the DMT-bearing admixture plant rather than Psychotria viridis (chacruna) used in Peru, producing different alkaloid profiles and different ceremony characters (Brito-da-Costa et al., 2020; Chambers et al., 2020). Rigorous medical and psychiatric screening before you arrive. A healer with traceable lineage and community accountability, not just a compelling personal story. Clear emergency protocols. Integration support both before and after ceremony. Transparency about what the ceremony involves and what to expect. Any provider who is casual about medications, who does not ask about your psychiatric history, or who cannot explain clearly who trained them and how they are accountable to that tradition is a provider to avoid (Rossi et al., 2023; ICEERS, 2019). The quality of the container around the experience matters more than the location, the price, or the reviews.what is ayahuasca
Conclusion
The pharmacology is the gateway, not the destination.
Ayahuasca is a brew from the Amazon, a pharmacological partnership between a vine and a leaf, and a ceremonial technology refined over centuries by the peoples who developed it and still carry it. It contains DMT made orally active by MAOI beta-carbolines in the vine. It travels under dozens of names across four countries and many more indigenous nations. It has documented effects on brain networks, on depression, on trauma, on addiction. It carries real risks for people with certain psychiatric histories or medication combinations. It is illegal in most of the Western world and protected in the Amazon basin where it was born.
None of that is the most important thing to understand.
The most important questions are not pharmacological. They are: Who am I learning from, and do they have genuine roots in the tradition they are offering? What container is being held around this experience? Have I been honest about my health history and my medications? Do I actually respect what I am approaching, not as a product or a solution, but as something that belongs to living people and living land?
The brew does not answer those questions. You do.
References
CONAD Resolução No. 1. (2010). Conselho Nacional de Políticas sobre Drogas, Brazil.
DEA Diversion Control Division (2024). N,N-Dimethyltryptamine (DMT) Drug Fact Sheet.
García Molina, A. (2014). The Sound Tactics of Upper Putumayo Shamans. NEIP. (Master’s thesis)
Gonzales v. O Centro Espírita Beneficente União do Vegetal, 546 U.S. 418 (2006). U.S. Supreme Court.
ICEERS (2024). Ayahuasca Safety Profile. iceers.org
Sánchez Avilés, C., & Rebollo, N. (ICEERS) (2019). International Regulation of Ayahuasca Practices.
UNODC (1971). Convention on Psychotropic Substances, 1971. United Nations Office on Drugs and Crime.
About the Author
Yasha Shah is the founder of MahaDevi Ayahuasca, a retreat center in Colombia. He has been working with ayahuasca since 2017, with experience across hundreds of ceremonies as both a participant and retreat organizer. Trained within the Shipibo and Camsá traditions and holding psychedelic integration certifications from ICEERS and Onaya Science, his work bridges indigenous wisdom, harm-reduction principles, and practical integration for modern seekers. Yasha writes about ayahuasca, plant medicine, and psychedelics — covering integration, preparation, and harm reduction to help readers make informed and responsible decisions.